210 related articles for article (PubMed ID: 30419310)
1. Dancing from bottoms up - Roles of the POZ-ZF transcription factor Kaiso in Cancer.
Pierre CC; Hercules SM; Yates C; Daniel JM
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):64-74. PubMed ID: 30419310
[TBL] [Abstract][Full Text] [Related]
2. The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor.
Daniel JM; Reynolds AB
Mol Cell Biol; 1999 May; 19(5):3614-23. PubMed ID: 10207085
[TBL] [Abstract][Full Text] [Related]
3. Kaiso regulates Znf131-mediated transcriptional activation.
Donaldson NS; Nordgaard CL; Pierre CC; Kelly KF; Robinson SC; Swystun L; Henriquez R; Graham M; Daniel JM
Exp Cell Res; 2010 Jun; 316(10):1692-705. PubMed ID: 20303951
[TBL] [Abstract][Full Text] [Related]
4. The POZ-ZF transcription factor Kaiso (ZBTB33) induces inflammation and progenitor cell differentiation in the murine intestine.
Chaudhary R; Pierre CC; Nanan K; Wojtal D; Morone S; Pinelli C; Wood GA; Robine S; Daniel JM
PLoS One; 2013; 8(9):e74160. PubMed ID: 24040197
[TBL] [Abstract][Full Text] [Related]
5. Kaiso overexpression promotes intestinal inflammation and potentiates intestinal tumorigenesis in Apc(Min/+) mice.
Pierre CC; Longo J; Mavor M; Milosavljevic SB; Chaudhary R; Gilbreath E; Yates C; Daniel JM
Biochim Biophys Acta; 2015 Sep; 1852(9):1846-55. PubMed ID: 26073433
[TBL] [Abstract][Full Text] [Related]
6. The POZ-ZF transcription factor Znf131 is implicated as a regulator of Kaiso-mediated biological processes.
Robinson SC; Donaldson-Kabwe NS; Dvorkin-Gheva A; Longo J; He L; Daniel JM
Biochem Biophys Res Commun; 2017 Nov; 493(1):416-421. PubMed ID: 28882591
[TBL] [Abstract][Full Text] [Related]
7. A role for Kaiso-p120ctn complexes in cancer?
van Roy FM; McCrea PD
Nat Rev Cancer; 2005 Dec; 5(12):956-64. PubMed ID: 16294216
[TBL] [Abstract][Full Text] [Related]
8. Methylation-dependent regulation of hypoxia inducible factor-1 alpha gene expression by the transcription factor Kaiso.
Pierre CC; Longo J; Bassey-Archibong BI; Hallett RM; Milosavljevic S; Beatty L; Hassell JA; Daniel JM
Biochim Biophys Acta; 2015 Dec; 1849(12):1432-41. PubMed ID: 26514431
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer.
Dai SD; Wang Y; Miao Y; Zhao Y; Zhang Y; Jiang GY; Zhang PX; Yang ZQ; Wang EH
BMC Cancer; 2009 Jun; 9():178. PubMed ID: 19508730
[TBL] [Abstract][Full Text] [Related]
10. Kaiso depletion attenuates transforming growth factor-β signaling and metastatic activity of triple-negative breast cancer cells.
Bassey-Archibong BI; Kwiecien JM; Milosavljevic SB; Hallett RM; Rayner LG; Erb MJ; Crawford-Brown CJ; Stephenson KB; Bédard PA; Hassell JA; Daniel JM
Oncogenesis; 2016 Mar; 5(3):e208. PubMed ID: 26999717
[TBL] [Abstract][Full Text] [Related]
11. Kaiso differentially regulates components of the Notch signaling pathway in intestinal cells.
Robinson SC; Klobucar K; Pierre CC; Ansari A; Zhenilo S; Prokhortchouk E; Daniel JM
Cell Commun Signal; 2017 Jun; 15(1):24. PubMed ID: 28637464
[TBL] [Abstract][Full Text] [Related]
12. The transcriptional repressor Kaiso localizes at the mitotic spindle and is a constituent of the pericentriolar material.
Soubry A; Staes K; Parthoens E; Noppen S; Stove C; Bogaert P; van Hengel J; van Roy F
PLoS One; 2010 Feb; 5(2):e9203. PubMed ID: 20169156
[TBL] [Abstract][Full Text] [Related]
13. POZ for effect--POZ-ZF transcription factors in cancer and development.
Kelly KF; Daniel JM
Trends Cell Biol; 2006 Nov; 16(11):578-87. PubMed ID: 16996269
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to Kaiso: a novel transcription factor and p120ctn-binding protein.
Daniel JM; Ireton RC; Reynolds AB
Hybridoma; 2001 Jun; 20(3):159-66. PubMed ID: 11461664
[TBL] [Abstract][Full Text] [Related]
15. Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer.
Vermeulen JF; van de Ven RA; Ercan C; van der Groep P; van der Wall E; Bult P; Christgen M; Lehmann U; Daniel J; van Diest PJ; Derksen PW
PLoS One; 2012; 7(5):e37864. PubMed ID: 22662240
[TBL] [Abstract][Full Text] [Related]
16. Kaiso represses the cell cycle gene cyclin D1 via sequence-specific and methyl-CpG-dependent mechanisms.
Donaldson NS; Pierre CC; Anstey MI; Robinson SC; Weerawardane SM; Daniel JM
PLoS One; 2012; 7(11):e50398. PubMed ID: 23226276
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells.
Jones J; Wang H; Zhou J; Hardy S; Turner T; Austin D; He Q; Wells A; Grizzle WE; Yates C
Am J Pathol; 2012 Nov; 181(5):1836-46. PubMed ID: 22974583
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c.
Abisoye-Ogunniyan A; Lin H; Ghebremedhin A; Salam AB; Karanam B; Theodore S; Jones-Trich J; Davis M; Grizzle W; Wang H; Yates C
Cancer Lett; 2018 Sep; 431():1-10. PubMed ID: 29751044
[TBL] [Abstract][Full Text] [Related]
19. Kaiso (ZBTB33) subcellular partitioning functionally links LC3A/B, the tumor microenvironment, and breast cancer survival.
Singhal SK; Byun JS; Park S; Yan T; Yancey R; Caban A; Hernandez SG; Hewitt SM; Boisvert H; Hennek S; Bobrow M; Ahmed MSU; White J; Yates C; Aukerman A; Vanguri R; Bareja R; Lenci R; Farré PL; De Siervi A; Nápoles AM; Vohra N; Gardner K
Commun Biol; 2021 Feb; 4(1):150. PubMed ID: 33526872
[TBL] [Abstract][Full Text] [Related]
20. Kaiso represses the expression of glucocorticoid receptor via a methylation-dependent mechanism and attenuates the anti-apoptotic activity of glucocorticoids in breast cancer cells.
Zhou L; Zhong Y; Yang FH; Li ZB; Zhou J; Liu XH; Li M; Hu F
BMB Rep; 2016 Mar; 49(3):167-72. PubMed ID: 26424557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
